Ospina-Jimenez AF, Gomez AP, Rincon-Monroy MA, Per. A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks. Virology. 2025 Mar 5;606:110483
Influenza A virus (FLUAV) affects a wide range of hosts, including humans and animals, posing a threat to public health. In swine, H3N2 subtype is associated with human-to-swine spillovers of seasonal viruses. In Latin America, the molecular and antigenic characteristics of swine FLUAV H3N2, as well as its phylogenetic origin, are poorly understood. Therefore, the objective of this study was to characterize the first swine H3N2 detected in Colombia. The origin and lineage of the virus were estimated through phylogenetic and molecular clock analyses. Antigenic characterization was achieved by comparing the amino acid constitution of the HA with previously reported swine FLUAVs and seasonal vaccine strains using a sequence-based method. In addition to HA and NA, internal genes were also characterized. The results showed that the Colombian H3N2 corresponded to a novel phylogenetic and antigenic swine FLUAV variant that emerged due to an independent reverse zoonotic event, likely occurring in Colombia in the early 2000s. The immunodominant epitope in the virus was predominantly present in antigenic epitope A, which showed the highest amino acid variation. Some mutations that alter the N-Glycosylation of antigenic sites at the HA were detected. Internally, the virus exhibited pandemic configuration. This study provides the first evidence of a novel FLUAV in Colombia and describes its origin, variability, and persistence in geographically restricted populations, highlighting the need for strengthen molecular surveillance of the virus in animal populations.
See Also:
Latest articles in those days:
- Polymerase trapping as the mechanism of H5 highly pathogenic avian influenza virus genesis 4 hours ago
- Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026 4 hours ago
- Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026 4 hours ago
- Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25 4 hours ago
- Influenza virus infection drives upregulation of CD84 across a broad range of immune cells 4 hours ago
[Go Top] [Close Window]


